Learn / NGNE
NASDAQ: NGNE
Neurogene (NGNE) stock, explained like you're 5
Neurogene trades on the Nasdaq under the ticker NGNE. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 528 million dollars.
- Ticker
- NGNE
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 528 million dollars
Is Neurogene a small, medium or large cap company?
No. Neurogene is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 528 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Neurogene makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NGNE stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Neurogene (Nasdaq:NGNE) Stock Analysis (Simply Wall Street)
- $NGNE stock is down 10% today. Here's what we see in our data. (Quiver Quantitative)
- NGNE Oct 2026 50.000 call (NGNE261016C00050000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Trading Systems Reacting to (NGNE) Volatility (Stock Traders Daily)
- Prudential Financial Inc. Opens New Position in Neurogene Inc. (NGNE) With 2.23 Million Share Purchase (GuruFocus)
Follow NGNE in your daily brief
Each trading day at 5 PM ET we post what happened to Neurogene and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NGNE
Questions about Neurogene stock
What does Neurogene do?
Neurogene trades on the Nasdaq under the ticker NGNE. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 528 million dollars.
What is the ticker symbol for Neurogene?
Neurogene trades under the ticker NGNE on the Nasdaq.
What is Neurogene's market cap?
Neurogene is a small cap stock with a market cap of about 528 million dollars.
How does Neurogene make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NGNE stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NGNE stock every day?
Add NGNE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.